The Effect of Both Ultrasound and Fluoroscopy Guide Erector Spinae Plane Blocks
1 other identifier
interventional
70
1 country
1
Brief Summary
Since the original publication on the erector spinae plane (ESP) block in 2016, the technique of the ESP block has evolved significantly in the last few years. Current reports suggest that the ESP block provides adequate analgesia in thoracic and abdominal sites in a post-surgical and chronic pain patient. However, there were still inconsistencies and unclear spread of local anesthetics in ultrasound guide ESP block. This study focusing on the spread of local anesthetic in ESP block under ultrasound and fluoroscopy and possible mechanisms of action.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2021
CompletedFirst Submitted
Initial submission to the registry
September 5, 2021
CompletedFirst Posted
Study publicly available on registry
September 14, 2021
CompletedSeptember 28, 2021
September 1, 2020
4 months
September 5, 2021
September 22, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Pain scale
reduction of Visual Analogue Scale
12 months
Study Arms (1)
ESP block
EXPERIMENTALESP block under mixed local anesthetics, betamethasone agent
Interventions
Eligibility Criteria
You may qualify if:
- Thirty-five patients in each group of breast tumor surgery and pain intervention procedure patients.
- Age \> 20
You may not qualify if:
- Unable to complete questionnaires.
- With coagulopathy
- History of thoracic spine trauma or surgery.
- Allergy to contrast local anesthetics and medium (Iohexol)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Cancer Center
Taipei County, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 5, 2021
First Posted
September 14, 2021
Study Start
April 20, 2021
Primary Completion
September 1, 2021
Study Completion
September 1, 2021
Last Updated
September 28, 2021
Record last verified: 2020-09